Nasal Airflow to Modulate Dyspnea in Tracheostomized Patients

Starting soon · Not applicable

Conditions studied: Ventilated Patients

In brief

The hypothesis of the present study is that restoring nasal stimulation alleviates dyspnea and improves respiratory drive. The aim of this study is to compare three non-pharmacological approaches designed to restore nasal stimulation (continuous nasal airflow, nasal sprays, and facial airflow) in tracheotomized patients dependent on mechanical ventilation.

Key facts

Study ID

NCT07308171

Run by

Assistance Publique - Hôpitaux de Paris

People needed

24

Starts

2026-02-01

Expected to finish

2027-02-01

Last updated by the study team

2026-01-29

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age ≥ 18 years
• Tracheostomy and mechanical ventilation
• Dyspnea ≥3
• Consent to participate
• Affiliation to health insurance

You may not qualify if…

• Agitation, delirium
• Continuous use of sedatives
• Patients under law protection
• Inmates
• Patients without health insurance
• Breastfeeding and pregnancy

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.